Sign in
4

Changes in Ownership

Cue Biopharma, Inc. Filed Acc 0001209191-20-008793

Options or other derivatives

  • CEO acquired 300,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
PASSERI DANIEL R CEO 2020-02-05 Grant or award · Stock Option (right to buy) +150,000 150,000 D: show line 1 in the form
PASSERI DANIEL R CEO 2020-02-05 Grant or award · Restricted Stock Units +150,000 150,000 D: show line 2 in the form
Loading xslF345X03/doc4.xml…